Literature DB >> 18562955

Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.

Mei-Hsuan Wu1, Yu-Ching Chou, Cheng-Pung Yu, Tsan Yang, San-Lin You, Chien-Jen Chen, Chien-An Sun.   

Abstract

The length of a polymorphic CAG repeat in exon 1 of the androgen receptor (AR) is inversely correlated with AR transactivation activity. As heightened androgenic stimulation may oppose breast cell proliferation, which is mediated by AR, we examined whether AR-CAG repeat lengths are related to breast cancer susceptibility. A nested case-control study of 88 newly diagnosed cases of breast cancer between 1992 and 2000 and 334 matched controls was carried out in Taiwanese women. Risk factors were obtained through a standardized questionnaire interview and blood samples were collected and used to determine the number of AR-CAG repeats. Women with one or more long AR (CAG)n repeat alleles (>22 repeats) were not at significantly increased risk of breast cancer [odds ratio (OR), 1.52; 95% confidence interval (CI), 0.80-2.90]. Of particular interest was a significantly increased risk associated with the long-allele AR genotype that was present mostly among women with a short duration (<10 years) of early estrogen exposure, as indicated by the interval between age at menarche and age at first full-term pregnancy, as compared with short AR allele genotypes (OR, 2.70; 95% CI, 1.00-7.31), although no such significant association in women with a long duration of early estrogen exposure (OR, 0.70; 95% CI, 0.25-1.59) was detected. These data suggest that longer AR (CAG)n repeat alleles may confer an increased risk of breast cancer among particular subsets of individuals, although these findings need replication in other populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562955     DOI: 10.1097/CEJ.0b013e3282f75e7f

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  8 in total

1.  Implications of single nucleotide polymorphisms in CD44 exon 2 for risk of breast cancer.

Authors:  Juhua Zhou; Prakash S Nagarkatti; Yin Zhong; Jiajia Zhang; Mitzi Nagarkatti
Journal:  Eur J Cancer Prev       Date:  2011-09       Impact factor: 2.497

2.  Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women.

Authors:  Lori C Sakoda; Christie R Blackston; Jennifer A Doherty; Roberta M Ray; Ming Gang Lin; Dao Li Gao; Helge Stalsberg; Ziding Feng; David B Thomas; Chu Chen
Journal:  Cancer Epidemiol       Date:  2010-09-17       Impact factor: 2.984

3.  Ethnic variation in allele distribution of the androgen receptor (AR) (CAG)n repeat.

Authors:  Christine M Ackerman; Lynn P Lowe; Hoon Lee; M Geoffrey Hayes; Alan R Dyer; Boyd E Metzger; William L Lowe; Margrit Urbanek
Journal:  J Androl       Date:  2011-05-19

Review 4.  Trinucleotide repeat expansions in human breast cancer-susceptibility genes: relevant targets for aspirin chemoprevention?

Authors:  M A Altinoz; N E Tunalı
Journal:  Clin Transl Oncol       Date:  2015-07-22       Impact factor: 3.405

Review 5.  CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies.

Authors:  Qixing Mao; Mantang Qiu; Gaochao Dong; Wenjie Xia; Shuai Zhang; Youtao Xu; Jie Wang; Yin Rong; Lin Xu; Feng Jiang
Journal:  Onco Targets Ther       Date:  2015-08-13       Impact factor: 4.147

Review 6.  Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms.

Authors:  Zeinab Safarpour Lima; Mostafa Ghadamzadeh; Farzad Tahmasebi Arashloo; Ghazaleh Amjad; Mohammad Reza Ebadi; Ladan Younesi
Journal:  J Hematol Oncol       Date:  2019-04-11       Impact factor: 17.388

7.  Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women.

Authors:  Yonglan Zheng; Dezheng Huo; Jing Zhang; Toshio F Yoshimatsu; Qun Niu; Olufunmilayo I Olopade
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

8.  Increased expression of ACTH (MC2R) and androgen (AR) receptors in giant bilateral myelolipomas from patients with congenital adrenal hyperplasia.

Authors:  Madson Q Almeida; Laura C Kaupert; Luciana P Brito; Antonio M Lerario; Beatriz M P Mariani; Marta Ribeiro; Osmar Monte; Francisco T Denes; Berenice B Mendonca; Tânia A S S Bachega
Journal:  BMC Endocr Disord       Date:  2014-05-12       Impact factor: 2.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.